Skip to main content

$100 million more from Gates

The linkurl:Bill & Melinda Gates Foundation;https://www.the-scientist.com/article/display/25259/ has established a new five-year $100 million fast-track grant program for global health research. Each project will receive $100,000, with the option of additional funding if merited. The program, which will adopt a fast-track review, is for scientists with "creative concepts" to fight global health scourges affecting developing countries, such as vaccines, drugs, and diagnostics. One of the

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
The linkurl:Bill & Melinda Gates Foundation;https://www.the-scientist.com/article/display/25259/ has established a new five-year $100 million fast-track grant program for global health research. Each project will receive $100,000, with the option of additional funding if merited. The program, which will adopt a fast-track review, is for scientists with "creative concepts" to fight global health scourges affecting developing countries, such as vaccines, drugs, and diagnostics. One of the goals of the initiative is to "support paradigm-changing ideas that have never before been tested, and that might not stand up to traditional peer review." To expedite the review process, funding proposals should be "relatively short" and can avoid preliminary data, they will be reviewed within three months, and grants can be awarded several times per year. The first call for proposals will appear in early 2008, on the linkurl:Grand Challenges in Global Health;https://www.gcgh.org/channels/gcgh Web site. James Aiken, President and Chief Executive Officer, Keystone Symposia on Molecular & Cellular Biology, took it upon himself to send an Email about the program to Keystone participants: "Keystone Symposia never shares, and only rarely uses our mailing lists for anything other than Keystone Symposia business. In this case, however, I felt that this new opportunity for grants was something that most of our participants would like to know about."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation